Table: Shin Nippon Biomedical -2020/21 group results

Shin Nippon Biomedical Laboratories

10/05/2021 07:00

May 10 (Reuters)- 
          Shin Nippon Biomedical Laboratories Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           15.11           14.56          15.98         7.46    
               (+3.8 pct)      (-7.0 pct)     (+5.8 pct)    (+6.4 pct) 
  Operating        2.53            2.23           2.55         1.22    
               (+13.5 pct)    (+168.5 pct)    (+0.8 pct)    (+5.0 pct) 
  Recurring        3.65            3.12           3.20         1.55    
               (+16.8 pct)     (+93.4 pct)    (-12.2 pct)  (+18.8 pct) 
  Net
  Net              3.66            2.55           3.90         1.54    
               (+43.6 pct)     (+30.8 pct)    (+6.5 pct)   (+35.2 pct) 
  EPS           87.95 yen       61.25 yen      93.67 yen    36.99 yen  
  Ann Div       20.00 yen       5.00 yen       20.00 yen               
  -Q2 Div          NIL             NIL                                 
  -Q4 Div       20.00 yen       5.00 yen       20.00 yen               
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T